Dr Roselia Guillen-santana, MD | |
6200 Beach Channel Dr, Arverne, NY 11692-1409 | |
(718) 945-7150 | |
Not Available |
Full Name | Dr Roselia Guillen-santana |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 6200 Beach Channel Dr, Arverne, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235140922 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 240701 (New York) | Primary |
Entity Name | South Nassau Family Medicine Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902891781 PECOS PAC ID: 4688563463 Enrollment ID: O20040311000216 |
News Archive
Doctors across the country including Tahsina Atiquzzaman in Kissimmee, Fla., are "shredding paper charts and ushering in digital records as part of the health care milestones announced last month by the federal government," The Orlando Sentinel/Modesto Bee reports.
Patients with type 2 diabetes* or prediabetes* are more likely to develop congestive heart failure (CHF) when given rosiglitazone or pioglitazone, as compared with controls. However these drugs did not increase the risk of cardiovascular death (CVD) for these patients.
"Southern African governments could use public spending in their battle against the extremely high rates of HIV/AIDS in their countries and still achieve a positive economic impact, argues a new paper from the African Development Bank (AfDB)," an AfDB press release states.
A large, international study published Online First in The Lancet reveals alarming levels of tuberculosis (TB) that are resistant to both first-line and second-line drugs. The findings show high prevalence of resistance to at least one second-line drug (43.7%) among multidrug-resistant (MDR) TB patients from eight countries in Africa, Asia, Europe, and Latin America. Worse still, the study found higher than expected overall levels of extensively drug-resistant (XDR) TB.
› Verified 9 days ago
Entity Name | Sun River Health Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568526838 PECOS PAC ID: 6608783568 Enrollment ID: O20040714000375 |
News Archive
Doctors across the country including Tahsina Atiquzzaman in Kissimmee, Fla., are "shredding paper charts and ushering in digital records as part of the health care milestones announced last month by the federal government," The Orlando Sentinel/Modesto Bee reports.
Patients with type 2 diabetes* or prediabetes* are more likely to develop congestive heart failure (CHF) when given rosiglitazone or pioglitazone, as compared with controls. However these drugs did not increase the risk of cardiovascular death (CVD) for these patients.
"Southern African governments could use public spending in their battle against the extremely high rates of HIV/AIDS in their countries and still achieve a positive economic impact, argues a new paper from the African Development Bank (AfDB)," an AfDB press release states.
A large, international study published Online First in The Lancet reveals alarming levels of tuberculosis (TB) that are resistant to both first-line and second-line drugs. The findings show high prevalence of resistance to at least one second-line drug (43.7%) among multidrug-resistant (MDR) TB patients from eight countries in Africa, Asia, Europe, and Latin America. Worse still, the study found higher than expected overall levels of extensively drug-resistant (XDR) TB.
› Verified 9 days ago
Entity Name | Mount Sinai School Of Medicine |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508127531 PECOS PAC ID: 6406096544 Enrollment ID: O20130712000368 |
News Archive
Doctors across the country including Tahsina Atiquzzaman in Kissimmee, Fla., are "shredding paper charts and ushering in digital records as part of the health care milestones announced last month by the federal government," The Orlando Sentinel/Modesto Bee reports.
Patients with type 2 diabetes* or prediabetes* are more likely to develop congestive heart failure (CHF) when given rosiglitazone or pioglitazone, as compared with controls. However these drugs did not increase the risk of cardiovascular death (CVD) for these patients.
"Southern African governments could use public spending in their battle against the extremely high rates of HIV/AIDS in their countries and still achieve a positive economic impact, argues a new paper from the African Development Bank (AfDB)," an AfDB press release states.
A large, international study published Online First in The Lancet reveals alarming levels of tuberculosis (TB) that are resistant to both first-line and second-line drugs. The findings show high prevalence of resistance to at least one second-line drug (43.7%) among multidrug-resistant (MDR) TB patients from eight countries in Africa, Asia, Europe, and Latin America. Worse still, the study found higher than expected overall levels of extensively drug-resistant (XDR) TB.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Roselia Guillen-santana, MD 222 Hoffman St, Franklin Square, NY 11010-2321 Ph: (516) 673-4135 | Dr Roselia Guillen-santana, MD 6200 Beach Channel Dr, Arverne, NY 11692-1409 Ph: (718) 945-7150 |
News Archive
Doctors across the country including Tahsina Atiquzzaman in Kissimmee, Fla., are "shredding paper charts and ushering in digital records as part of the health care milestones announced last month by the federal government," The Orlando Sentinel/Modesto Bee reports.
Patients with type 2 diabetes* or prediabetes* are more likely to develop congestive heart failure (CHF) when given rosiglitazone or pioglitazone, as compared with controls. However these drugs did not increase the risk of cardiovascular death (CVD) for these patients.
"Southern African governments could use public spending in their battle against the extremely high rates of HIV/AIDS in their countries and still achieve a positive economic impact, argues a new paper from the African Development Bank (AfDB)," an AfDB press release states.
A large, international study published Online First in The Lancet reveals alarming levels of tuberculosis (TB) that are resistant to both first-line and second-line drugs. The findings show high prevalence of resistance to at least one second-line drug (43.7%) among multidrug-resistant (MDR) TB patients from eight countries in Africa, Asia, Europe, and Latin America. Worse still, the study found higher than expected overall levels of extensively drug-resistant (XDR) TB.
› Verified 9 days ago
Abimbola Oduguwa, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 6200 Beach Channel Dr, Arverne, NY 11692 Phone: 718-945-7150 | |
Dr. Betty A Chua, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6200 Beach Channel Dr, Arverne, NY 11692 Phone: 718-945-7150 | |
Dr. Sanga Bunyavanich, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 6200 Beach Channel Dr, Arverne, NY 11692 Phone: 718-945-7150 Fax: 718-663-6133 |